Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B? | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article Text

Leading article

Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?

https://doi.org/10.1136/gutjnl-2011-301096

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Competing interests HLAJ received grants from and is a consultant for Bristol Myers Squibb, Gilead Sciences, Novartis, Roche and Merck. MRB is on the speaker bureau/advisor of Abbott, BMS, Gilead, Hoffmann-la Roche and Merck. MJS has nothing to disclose.
Provenance and peer review Commissioned; externally peer reviewed.

Read the full text or download the PDF: